Related Experiment Videos
[Auto-immune-like disease post-bone marrow transplantation].
S Vinzio1, B Lioure, F Grunenberger
1Service de médecine interne et nutrition, hôpital de Hautepierre, avenue Molière, 67098 Strasbourg cedex, France. stephane.vinzio@chru-strasbourg.fr
La Revue De Medecine Interne
|June 29, 2004
Summary
Bone marrow transplantation (BMT) can lead to chronic graft-vs-host disease (GVH), mimicking autoimmune disorders. Understanding these post-BMT conditions offers insights into primary autoimmune diseases.
Area of Science:
- Hematology
- Immunology
- Transplantation Medicine
Context:
- Bone marrow transplantation (BMT) involves destroying patient marrow and replacing it with donor stem cells.
- Chronic graft-vs-host disease (GVH) is a significant BMT complication, presenting with autoimmune-like symptoms.
- Various autoimmune conditions, including scleroderma and myasthenia gravis, are observed post-BMT.
Purpose:
- To explore the autoimmune-like manifestations following BMT.
- To understand the pathophysiology of chronic GVH and related autoimmune disorders.
- To investigate the mechanisms behind post-BMT autoimmune phenomena.
Summary:
- Chronic GVH and other autoimmune-like diseases post-BMT are poorly understood.
- Potential mechanisms include inadequate immune recovery, lymphocyte imbalance, microchimerism, and molecular mimicry.
- Some cases, like autoimmune thyroid disorders, result from direct donor cell transfer.
Impact:
- Post-BMT autoimmune-like disorders serve as valuable models for studying primary autoimmune diseases.
- Further research can elucidate shared pathogenic pathways.
- This understanding may lead to improved BMT protocols and autoimmune disease management.